200 related articles for article (PubMed ID: 21339756)
1. Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation.
Gandillet A; Park S; Lassailly F; Griessinger E; Vargaftig J; Filby A; Lister TA; Bonnet D
Leukemia; 2011 May; 25(5):770-780. PubMed ID: 21339756
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
3. Proliferation and bone marrow engraftment of AML blasts is dependent on β-catenin signalling.
Siapati EK; Papadaki M; Kozaou Z; Rouka E; Michali E; Savvidou I; Gogos D; Kyriakou D; Anagnostopoulos NI; Vassilopoulos G
Br J Haematol; 2011 Jan; 152(2):164-74. PubMed ID: 21118196
[TBL] [Abstract][Full Text] [Related]
4. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153
[TBL] [Abstract][Full Text] [Related]
5. γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin.
Morgan RG; Pearn L; Liddiard K; Pumford SL; Burnett AK; Tonks A; Darley RL
Leukemia; 2013 Feb; 27(2):336-43. PubMed ID: 22858986
[TBL] [Abstract][Full Text] [Related]
6. An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML.
Carter BZ; Mak PY; Wang X; Tao W; Ruvolo V; Mak D; Mu H; Burks JK; Andreeff M
Cancer Res; 2019 Mar; 79(6):1165-1177. PubMed ID: 30674535
[TBL] [Abstract][Full Text] [Related]
7. SOX12: a novel potential target for acute myeloid leukaemia.
Wan H; Cai J; Chen F; Zhu J; Zhong J; Zhong H
Br J Haematol; 2017 Feb; 176(3):421-430. PubMed ID: 27858992
[TBL] [Abstract][Full Text] [Related]
8. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
[No Abstract] [Full Text] [Related]
9. LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating β-catenin/c-Myc signaling.
Wang Y; Tong H; Wang J; Hu L; Huang Z
J Mol Histol; 2024 Feb; 55(1):37-50. PubMed ID: 38165568
[TBL] [Abstract][Full Text] [Related]
10. LncRNA-DUXAP8 Regulation of the Wnt/β-Catenin Signaling Pathway to Inhibit Glycolysis and Induced Apoptosis in Acute Myeloid Leukemia.
Zhai H; Zhao J; Pu J; Zhao P; Wei J
Turk J Haematol; 2021 Dec; 38(4):264-272. PubMed ID: 34431643
[TBL] [Abstract][Full Text] [Related]
11. Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia.
Man CH; Fung TK; Wan H; Cher CY; Fan A; Ng N; Ho C; Wan TS; Tanaka T; So CW; Kwong YL; Leung AY
Blood; 2015 Jun; 125(25):3928-36. PubMed ID: 25940713
[TBL] [Abstract][Full Text] [Related]
12. The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.
Tarighat SS; Santhanam R; Frankhouser D; Radomska HS; Lai H; Anghelina M; Wang H; Huang X; Alinari L; Walker A; Caligiuri MA; Croce CM; Li L; Garzon R; Li C; Baiocchi RA; Marcucci G
Leukemia; 2016 Apr; 30(4):789-99. PubMed ID: 26536822
[TBL] [Abstract][Full Text] [Related]
13. Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice.
Salvestrini V; Zini R; Rossi L; Gulinelli S; Manfredini R; Bianchi E; Piacibello W; Caione L; Migliardi G; Ricciardi MR; Tafuri A; Romano M; Salati S; Di Virgilio F; Ferrari S; Baccarani M; Ferrari D; Lemoli RM
Blood; 2012 Jan; 119(1):217-26. PubMed ID: 22053107
[TBL] [Abstract][Full Text] [Related]
14. LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells.
Morgan RG; Ridsdale J; Payne M; Heesom KJ; Wilson MC; Davidson A; Greenhough A; Davies S; Williams AC; Blair A; Waterman ML; Tonks A; Darley RL
Haematologica; 2019 Jul; 104(7):1365-1377. PubMed ID: 30630973
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of TRIM24 suppresses growth and induces apoptosis in acute myeloid leukemia through downregulation of Wnt/GSK-3β/β-catenin signaling.
Li C; Xin H; Shi Y; Mu J
Hum Exp Toxicol; 2020 Dec; 39(12):1725-1736. PubMed ID: 32672070
[TBL] [Abstract][Full Text] [Related]
16. SOSTDC1 acts as a tumor inhibitor in acute myeloid leukemia by downregulating the Wnt/β-catenin pathway.
Li C; Wang M; Shi Y; Xin H
Environ Toxicol; 2022 Aug; 37(8):1934-1943. PubMed ID: 35442555
[TBL] [Abstract][Full Text] [Related]
17. TCTP promotes glioma cell proliferation in vitro and in vivo via enhanced β-catenin/TCF-4 transcription.
Gu X; Yao L; Ma G; Cui L; Li Y; Liang W; Zhao B; Li K
Neuro Oncol; 2014 Jan; 16(2):217-27. PubMed ID: 24311645
[TBL] [Abstract][Full Text] [Related]
18. GPR84 sustains aberrant β-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis.
Dietrich PA; Yang C; Leung HH; Lynch JR; Gonzales E; Liu B; Haber M; Norris MD; Wang J; Wang JY
Blood; 2014 Nov; 124(22):3284-94. PubMed ID: 25293777
[TBL] [Abstract][Full Text] [Related]
19. AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX/β-catenin signaling pathway.
Zhang Y; Wang J; Wheat J; Chen X; Jin S; Sadrzadeh H; Fathi AT; Peterson RT; Kung AL; Sweetser DA; Yeh JR
Blood; 2013 Jun; 121(24):4906-16. PubMed ID: 23645839
[TBL] [Abstract][Full Text] [Related]
20. Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis.
Ysebaert L; Chicanne G; Demur C; De Toni F; Prade-Houdellier N; Ruidavets JB; Mansat-De Mas V; Rigal-Huguet F; Laurent G; Payrastre B; Manenti S; Racaud-Sultan C
Leukemia; 2006 Jul; 20(7):1211-6. PubMed ID: 16688229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]